New technology aims to help people suffering from sinus problems and allergies
video

Dr. Jay Pinto from University of Chicago Medicine talks about a new delivery device that helps medicine travel deeper into the sinuses and reduce symptoms.

Flu season hitting US earlier and harder in 2022
video

Fox medical contributor Dr. Mike Cirigliano walks us through the latest headlines coming out of the medical community and talks about why flu season could be especially potent this year.

Illinois AG Raoul urges FDA to approve over-the-counter birth control pill

Illinois Attorney General Kwame Raoul has joined a 21-state coalition urging the Food and Drug Administration to approve the country's first over-the-counter birth control pill.

Illinois AG Raoul urges FDA to approve over-the-counter birth control pill
video

Illinois Attorney General Kwame Raoul has joined a 21-state coalition urging the Food and Drug Administration to approve the country's first over-the-counter birth control pill.

Pros and cons of using telehealth apps and appointments
video

Dr. Shikha Jain from UI Health talks about the benefits and pitfalls of companies who use telehealth apps and appointments as their primary business model.

Children's hospitals see nationwide surge of RSV infections
video

Dr. Tina Tan, infectious diseases physician at Lurie Children's Hospital, talks about the trends they are seeing with RSV infections and their impact on children.

Chicago non-profit prepares free meals for patients fighting cancer
video

Free restaurant-prepared meals are being given to people who've been diagnosed with and are undergoing cancer treatment at Chicago hospitals, thanks to one local non-profit. Courtney White, president and founder of Culinary Care, talks about these very special deliveries.

How beauty products could be impacting your cancer risk
video

Dr. Flora Stay, founder of Cleure, talks about how certain beauty treatments can affect your body and what that means for the risk of developing cancer.

Pfizer says COVID-19 vaccine will cost $110-$130 per dose

Pfizer said the commercial pricing for adult COVID-19 vaccine doses could start in early 2023, depending on when the U.S. government phases out its program of buying the shots.